Richard Hamman
Concepts (757)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Diabetes Mellitus, Type 2 | 109 | 2022 | 2001 | 5.350 |
Why?
| Diabetes Mellitus, Type 1 | 86 | 2022 | 3262 | 3.840 |
Why?
| Diabetes Mellitus | 25 | 2021 | 960 | 1.930 |
Why?
| Cholesterol, HDL | 21 | 2020 | 235 | 1.510 |
Why?
| Cardiovascular Diseases | 25 | 2019 | 1695 | 1.490 |
Why?
| Colorado | 100 | 2021 | 4552 | 1.370 |
Why?
| Polymorphism, Genetic | 25 | 2011 | 775 | 1.270 |
Why?
| Glucose Tolerance Test | 31 | 2012 | 393 | 1.210 |
Why?
| Diabetic Angiopathies | 17 | 2018 | 299 | 1.210 |
Why?
| Female | 253 | 2022 | 62624 | 1.190 |
Why?
| Risk Factors | 100 | 2021 | 8978 | 1.180 |
Why?
| Male | 233 | 2022 | 60715 | 1.160 |
Why?
| Prevalence | 48 | 2021 | 2383 | 1.080 |
Why?
| Life Style | 17 | 2019 | 437 | 1.060 |
Why?
| Blood Glucose | 33 | 2022 | 1908 | 1.040 |
Why?
| Vascular Stiffness | 8 | 2018 | 378 | 1.030 |
Why?
| Humans | 296 | 2022 | 112249 | 1.000 |
Why?
| Adolescent | 102 | 2022 | 18577 | 0.990 |
Why?
| Lipids | 16 | 2020 | 619 | 0.990 |
Why?
| Adult | 150 | 2022 | 31789 | 0.960 |
Why?
| Body Mass Index | 39 | 2017 | 2076 | 0.950 |
Why?
| Activities of Daily Living | 7 | 2005 | 361 | 0.930 |
Why?
| Triglycerides | 19 | 2020 | 542 | 0.910 |
Why?
| Incidence | 38 | 2021 | 2453 | 0.890 |
Why?
| Diabetes, Gestational | 8 | 2012 | 263 | 0.870 |
Why?
| Glucose Intolerance | 7 | 2007 | 127 | 0.870 |
Why?
| Aged | 111 | 2019 | 20025 | 0.860 |
Why?
| Insulin | 30 | 2014 | 2167 | 0.860 |
Why?
| Middle Aged | 142 | 2019 | 28676 | 0.850 |
Why?
| Registries | 21 | 2021 | 1805 | 0.850 |
Why?
| Coronary Disease | 13 | 2012 | 469 | 0.830 |
Why?
| Rural Population | 13 | 2006 | 472 | 0.830 |
Why?
| Cholesterol, LDL | 12 | 2020 | 323 | 0.810 |
Why?
| Obesity | 22 | 2017 | 2602 | 0.790 |
Why?
| Insulin Resistance | 22 | 2015 | 1140 | 0.770 |
Why?
| Child | 85 | 2022 | 17357 | 0.770 |
Why?
| Adiposity | 8 | 2019 | 482 | 0.750 |
Why?
| Hypoglycemic Agents | 18 | 2014 | 1018 | 0.730 |
Why?
| Cholesterol | 12 | 2020 | 384 | 0.730 |
Why?
| Glycated Hemoglobin A | 21 | 2022 | 822 | 0.700 |
Why?
| Environmental Pollutants | 4 | 2020 | 98 | 0.680 |
Why?
| Prediabetic State | 9 | 2017 | 227 | 0.670 |
Why?
| Metformin | 15 | 2017 | 281 | 0.670 |
Why?
| Young Adult | 44 | 2022 | 10899 | 0.670 |
Why?
| Diabetes Complications | 9 | 2021 | 249 | 0.640 |
Why?
| Breast Feeding | 7 | 2012 | 347 | 0.610 |
Why?
| Blood Pressure | 13 | 2017 | 1755 | 0.610 |
Why?
| United States | 51 | 2021 | 12170 | 0.610 |
Why?
| Apolipoproteins E | 7 | 2019 | 103 | 0.600 |
Why?
| Aging | 9 | 2008 | 1711 | 0.580 |
Why?
| Birth Weight | 4 | 2006 | 411 | 0.580 |
Why?
| Age of Onset | 9 | 2020 | 494 | 0.570 |
Why?
| Electronic Health Records | 5 | 2021 | 659 | 0.560 |
Why?
| Age Factors | 35 | 2018 | 3330 | 0.560 |
Why?
| Fluorocarbons | 3 | 2020 | 72 | 0.550 |
Why?
| Case-Control Studies | 31 | 2019 | 3353 | 0.530 |
Why?
| Infant | 36 | 2022 | 8024 | 0.530 |
Why?
| Diabetic Retinopathy | 7 | 2012 | 155 | 0.520 |
Why?
| Rural Health | 6 | 2002 | 96 | 0.520 |
Why?
| Maternal Exposure | 4 | 2019 | 134 | 0.510 |
Why?
| Child, Preschool | 43 | 2022 | 9655 | 0.510 |
Why?
| Cognition Disorders | 5 | 2013 | 584 | 0.510 |
Why?
| C-Peptide | 11 | 2012 | 143 | 0.500 |
Why?
| Sex Factors | 32 | 2019 | 1995 | 0.500 |
Why?
| Arteriosclerosis | 9 | 2005 | 111 | 0.500 |
Why?
| Regression Analysis | 23 | 2014 | 1136 | 0.490 |
Why?
| Weight Loss | 9 | 2012 | 692 | 0.490 |
Why?
| Cohort Studies | 29 | 2019 | 4937 | 0.480 |
Why?
| Carotid Arteries | 2 | 2013 | 194 | 0.480 |
Why?
| Infant, Newborn | 26 | 2020 | 5017 | 0.480 |
Why?
| Femoral Artery | 1 | 2013 | 163 | 0.480 |
Why?
| Environmental Exposure | 4 | 2020 | 423 | 0.470 |
Why?
| Lipase | 2 | 2020 | 84 | 0.470 |
Why?
| Multiple Trauma | 2 | 2005 | 100 | 0.460 |
Why?
| Health Surveys | 6 | 2013 | 497 | 0.460 |
Why?
| Diabetic Neuropathies | 5 | 2012 | 78 | 0.450 |
Why?
| Odds Ratio | 19 | 2008 | 1061 | 0.450 |
Why?
| Logistic Models | 19 | 2017 | 2049 | 0.450 |
Why?
| Dietary Fats | 7 | 2011 | 354 | 0.450 |
Why?
| Risk Assessment | 11 | 2019 | 3137 | 0.440 |
Why?
| Pregnancy Complications, Cardiovascular | 2 | 2003 | 76 | 0.440 |
Why?
| Genetic Variation | 10 | 2014 | 983 | 0.430 |
Why?
| Prenatal Exposure Delayed Effects | 5 | 2019 | 458 | 0.430 |
Why?
| Apolipoproteins C | 2 | 2019 | 10 | 0.420 |
Why?
| Exercise | 12 | 2018 | 1687 | 0.420 |
Why?
| Hypertension | 7 | 2017 | 1166 | 0.400 |
Why?
| Body Constitution | 5 | 2005 | 66 | 0.400 |
Why?
| Hyperinsulinism | 3 | 2013 | 111 | 0.400 |
Why?
| Socioeconomic Factors | 15 | 2018 | 1206 | 0.400 |
Why?
| Adiponectin | 4 | 2013 | 208 | 0.390 |
Why?
| Genotype | 25 | 2020 | 2070 | 0.380 |
Why?
| Physical Fitness | 4 | 2012 | 192 | 0.370 |
Why?
| African Americans | 11 | 2020 | 1096 | 0.370 |
Why?
| Disabled Persons | 2 | 2002 | 144 | 0.360 |
Why?
| Aged, 80 and over | 18 | 2013 | 6778 | 0.360 |
Why?
| Lipoproteins | 6 | 2019 | 182 | 0.360 |
Why?
| Apolipoproteins A | 6 | 2003 | 29 | 0.360 |
Why?
| Follow-Up Studies | 19 | 2017 | 4887 | 0.360 |
Why?
| Dietary Fiber | 4 | 2011 | 49 | 0.350 |
Why?
| Apolipoprotein A-I | 2 | 1997 | 27 | 0.350 |
Why?
| Gene Frequency | 18 | 2014 | 569 | 0.350 |
Why?
| Haplotypes | 10 | 2019 | 548 | 0.350 |
Why?
| Overweight | 5 | 2017 | 464 | 0.350 |
Why?
| Linkage Disequilibrium | 12 | 2015 | 330 | 0.350 |
Why?
| Fasting | 10 | 2017 | 278 | 0.340 |
Why?
| Diabetic Ketoacidosis | 4 | 2020 | 163 | 0.340 |
Why?
| Health Behavior | 4 | 2018 | 716 | 0.340 |
Why?
| Polymorphism, Single Nucleotide | 10 | 2020 | 2029 | 0.330 |
Why?
| Cross-Sectional Studies | 25 | 2021 | 4207 | 0.330 |
Why?
| Child Development | 3 | 2019 | 469 | 0.330 |
Why?
| Pregnancy | 18 | 2019 | 5185 | 0.320 |
Why?
| Health Status Disparities | 1 | 2008 | 219 | 0.320 |
Why?
| Longitudinal Studies | 10 | 2019 | 2673 | 0.310 |
Why?
| Autoantibodies | 6 | 2014 | 1208 | 0.310 |
Why?
| Alleles | 15 | 2020 | 905 | 0.310 |
Why?
| Erythropoietin | 1 | 2006 | 89 | 0.300 |
Why?
| Self-Injurious Behavior | 2 | 2017 | 105 | 0.300 |
Why?
| Diet | 9 | 2011 | 1070 | 0.290 |
Why?
| Retinopathy of Prematurity | 1 | 2006 | 75 | 0.290 |
Why?
| Ohio | 6 | 2015 | 128 | 0.290 |
Why?
| Femoral Fractures | 1 | 2005 | 74 | 0.290 |
Why?
| Indians, North American | 12 | 2020 | 597 | 0.280 |
Why?
| Carotid Intima-Media Thickness | 2 | 2015 | 66 | 0.280 |
Why?
| Lipoprotein Lipase | 5 | 2013 | 87 | 0.280 |
Why?
| Prospective Studies | 19 | 2021 | 6167 | 0.270 |
Why?
| Educational Status | 4 | 2008 | 406 | 0.270 |
Why?
| Uterine Cervical Neoplasms | 9 | 2002 | 206 | 0.260 |
Why?
| Algorithms | 5 | 2021 | 1548 | 0.260 |
Why?
| Heart Rate | 6 | 2013 | 842 | 0.250 |
Why?
| Energy Intake | 5 | 2017 | 493 | 0.250 |
Why?
| Mental Status Schedule | 2 | 1999 | 39 | 0.250 |
Why?
| Health Status | 3 | 2006 | 769 | 0.250 |
Why?
| Autism Spectrum Disorder | 2 | 2017 | 264 | 0.250 |
Why?
| Patient Compliance | 5 | 2014 | 604 | 0.250 |
Why?
| Smoking | 11 | 2014 | 1627 | 0.240 |
Why?
| Sex Distribution | 6 | 2008 | 395 | 0.240 |
Why?
| Pregnancy Complications | 1 | 2008 | 484 | 0.240 |
Why?
| Embryonic and Fetal Development | 1 | 2002 | 101 | 0.240 |
Why?
| Glycoproteins | 3 | 1999 | 350 | 0.240 |
Why?
| Leptin | 3 | 2014 | 225 | 0.240 |
Why?
| Health Promotion | 4 | 2018 | 660 | 0.230 |
Why?
| Catheters, Indwelling | 1 | 2002 | 90 | 0.230 |
Why?
| Lipoprotein(a) | 2 | 2000 | 46 | 0.230 |
Why?
| Retrospective Studies | 19 | 2019 | 11118 | 0.230 |
Why?
| Dyslipidemias | 4 | 2019 | 161 | 0.230 |
Why?
| Health Status Indicators | 1 | 2002 | 181 | 0.230 |
Why?
| Population Surveillance | 6 | 2016 | 438 | 0.230 |
Why?
| Alzheimer Disease | 3 | 2005 | 410 | 0.230 |
Why?
| Transcription Factor 7-Like 2 Protein | 2 | 2011 | 25 | 0.230 |
Why?
| Tungsten | 1 | 2021 | 31 | 0.220 |
Why?
| Endocrine Disruptors | 2 | 2019 | 44 | 0.220 |
Why?
| Confidence Intervals | 7 | 2008 | 347 | 0.220 |
Why?
| Genetic Association Studies | 4 | 2019 | 409 | 0.220 |
Why?
| Social Support | 3 | 2018 | 539 | 0.220 |
Why?
| Dietary Carbohydrates | 3 | 1997 | 160 | 0.220 |
Why?
| Apolipoproteins B | 2 | 2014 | 52 | 0.210 |
Why?
| Analysis of Variance | 13 | 2011 | 1517 | 0.210 |
Why?
| Cholesterol Ester Transfer Proteins | 2 | 2020 | 22 | 0.210 |
Why?
| Diet, Diabetic | 2 | 2011 | 37 | 0.210 |
Why?
| Reference Values | 10 | 2012 | 876 | 0.210 |
Why?
| Pulse Wave Analysis | 6 | 2018 | 160 | 0.210 |
Why?
| Mass Screening | 5 | 2020 | 1038 | 0.210 |
Why?
| India | 4 | 2020 | 152 | 0.210 |
Why?
| Folic Acid | 2 | 2016 | 153 | 0.210 |
Why?
| Spinal Cord Injuries | 1 | 2002 | 151 | 0.200 |
Why?
| Predictive Value of Tests | 12 | 2020 | 2021 | 0.200 |
Why?
| Genetic Predisposition to Disease | 10 | 2017 | 2406 | 0.200 |
Why?
| Multivariate Analysis | 11 | 2012 | 1599 | 0.200 |
Why?
| Cytosine | 1 | 2019 | 50 | 0.200 |
Why?
| Apolipoprotein C-II | 1 | 2019 | 3 | 0.200 |
Why?
| Apolipoprotein C-I | 1 | 2019 | 4 | 0.200 |
Why?
| Physical Exertion | 2 | 1991 | 250 | 0.200 |
Why?
| Urinary Bladder Neoplasms | 1 | 2002 | 190 | 0.200 |
Why?
| Nutrition Disorders | 1 | 1999 | 26 | 0.200 |
Why?
| Quality of Life | 4 | 2011 | 2089 | 0.200 |
Why?
| Mortality | 4 | 2010 | 327 | 0.200 |
Why?
| beta Carotene | 1 | 1998 | 21 | 0.190 |
Why?
| Risk | 11 | 2013 | 944 | 0.190 |
Why?
| Antioxidants | 2 | 2002 | 569 | 0.190 |
Why?
| Medical History Taking | 3 | 2000 | 127 | 0.190 |
Why?
| Abortion, Spontaneous | 1 | 1999 | 77 | 0.190 |
Why?
| Chromans | 3 | 2008 | 24 | 0.190 |
Why?
| Gardening | 1 | 2018 | 12 | 0.180 |
Why?
| Vitamin E | 1 | 1998 | 123 | 0.180 |
Why?
| Receptors, LDL | 2 | 1998 | 44 | 0.180 |
Why?
| Community Participation | 2 | 2018 | 130 | 0.180 |
Why?
| Cross-Cultural Comparison | 1 | 1998 | 79 | 0.180 |
Why?
| Comparative Effectiveness Research | 1 | 2019 | 143 | 0.180 |
Why?
| Ascorbic Acid | 1 | 1998 | 105 | 0.180 |
Why?
| Arteries | 2 | 2010 | 231 | 0.180 |
Why?
| Diet Therapy | 1 | 2018 | 39 | 0.180 |
Why?
| Fetal Blood | 3 | 2020 | 267 | 0.180 |
Why?
| Hyperglycemia | 5 | 2014 | 336 | 0.180 |
Why?
| Phthalic Acids | 1 | 2018 | 21 | 0.180 |
Why?
| Risk Reduction Behavior | 3 | 2017 | 217 | 0.180 |
Why?
| Disease Progression | 9 | 2018 | 2474 | 0.180 |
Why?
| Fertility | 1 | 2019 | 138 | 0.180 |
Why?
| Contraceptive Prevalence Surveys | 1 | 2017 | 1 | 0.180 |
Why?
| Sex Characteristics | 6 | 2010 | 659 | 0.180 |
Why?
| Ankle Brachial Index | 2 | 2015 | 31 | 0.170 |
Why?
| Phenols | 1 | 2018 | 76 | 0.170 |
Why?
| Reproductive Behavior | 1 | 2017 | 12 | 0.170 |
Why?
| Receptor, Melanocortin, Type 4 | 1 | 2017 | 11 | 0.170 |
Why?
| Glutamate Decarboxylase | 4 | 2014 | 164 | 0.170 |
Why?
| Alpha-Ketoglutarate-Dependent Dioxygenase FTO | 1 | 2017 | 22 | 0.170 |
Why?
| Linear Models | 6 | 2019 | 909 | 0.170 |
Why?
| Multiple Organ Failure | 1 | 1998 | 156 | 0.170 |
Why?
| Epidemiologic Methods | 5 | 1992 | 78 | 0.170 |
Why?
| Vitamin B 12 | 2 | 2016 | 118 | 0.170 |
Why?
| Time Factors | 16 | 2013 | 7054 | 0.170 |
Why?
| Calcinosis | 3 | 2011 | 296 | 0.170 |
Why?
| Thiazolidinediones | 3 | 2008 | 161 | 0.160 |
Why?
| Age Distribution | 5 | 2006 | 402 | 0.160 |
Why?
| Arsenic | 1 | 2016 | 38 | 0.160 |
Why?
| Islets of Langerhans | 4 | 2014 | 709 | 0.160 |
Why?
| Autonomic Nervous System | 2 | 2013 | 72 | 0.160 |
Why?
| Family Planning Services | 1 | 2017 | 70 | 0.160 |
Why?
| Lipoproteins, HDL | 3 | 2008 | 88 | 0.160 |
Why?
| Cognition | 2 | 2008 | 954 | 0.160 |
Why?
| Preventive Health Services | 1 | 2018 | 140 | 0.160 |
Why?
| Weight Reduction Programs | 1 | 2017 | 103 | 0.160 |
Why?
| Receptor-Like Protein Tyrosine Phosphatases, Class 8 | 2 | 2014 | 59 | 0.160 |
Why?
| International Classification of Diseases | 3 | 2021 | 114 | 0.160 |
Why?
| Diet, Atherogenic | 1 | 1995 | 10 | 0.160 |
Why?
| Peripheral Nervous System Diseases | 1 | 1997 | 137 | 0.150 |
Why?
| Milk | 2 | 1996 | 141 | 0.150 |
Why?
| Parity | 2 | 1993 | 100 | 0.150 |
Why?
| Brain-Derived Neurotrophic Factor | 1 | 2017 | 136 | 0.150 |
Why?
| Abdominal Fat | 2 | 2013 | 44 | 0.150 |
Why?
| Waist Circumference | 5 | 2018 | 131 | 0.150 |
Why?
| Biofeedback, Psychology | 1 | 1995 | 29 | 0.150 |
Why?
| Prognosis | 8 | 2013 | 3532 | 0.150 |
Why?
| Insulin-Secreting Cells | 2 | 2012 | 339 | 0.150 |
Why?
| Proportional Hazards Models | 6 | 2012 | 1130 | 0.150 |
Why?
| Renal Insufficiency, Chronic | 1 | 2021 | 461 | 0.150 |
Why?
| Scavenger Receptors, Class B | 1 | 2014 | 11 | 0.150 |
Why?
| Pediatric Obesity | 2 | 2018 | 390 | 0.140 |
Why?
| Body Composition | 3 | 2004 | 738 | 0.140 |
Why?
| Body Weight | 4 | 2010 | 1016 | 0.140 |
Why?
| Liver | 2 | 2003 | 1859 | 0.140 |
Why?
| PPAR gamma | 2 | 2007 | 180 | 0.140 |
Why?
| Dietary Supplements | 1 | 1998 | 430 | 0.140 |
Why?
| Biomarkers | 9 | 2020 | 3464 | 0.140 |
Why?
| Micronutrients | 1 | 1995 | 74 | 0.140 |
Why?
| Carrier Proteins | 3 | 2004 | 820 | 0.140 |
Why?
| Motor Activity | 3 | 2014 | 753 | 0.140 |
Why?
| Carbonated Beverages | 2 | 2011 | 23 | 0.140 |
Why?
| Blood Pressure Determination | 1 | 1995 | 127 | 0.140 |
Why?
| Peripheral Vascular Diseases | 1 | 1995 | 95 | 0.140 |
Why?
| Health Knowledge, Attitudes, Practice | 2 | 2006 | 1225 | 0.140 |
Why?
| HLA-A Antigens | 1 | 1994 | 46 | 0.140 |
Why?
| HLA-D Antigens | 1 | 1994 | 40 | 0.140 |
Why?
| Visual Perception | 1 | 1995 | 161 | 0.140 |
Why?
| HLA-B Antigens | 1 | 1994 | 51 | 0.140 |
Why?
| Chi-Square Distribution | 4 | 2003 | 572 | 0.140 |
Why?
| DNA | 3 | 2000 | 1405 | 0.140 |
Why?
| Weight Gain | 2 | 1995 | 487 | 0.140 |
Why?
| Gestational Age | 3 | 2011 | 765 | 0.130 |
Why?
| Brachial Artery | 3 | 2013 | 193 | 0.130 |
Why?
| Diabetic Cardiomyopathies | 1 | 2014 | 39 | 0.130 |
Why?
| Seasons | 4 | 1994 | 439 | 0.130 |
Why?
| Prenatal Nutritional Physiological Phenomena | 1 | 2014 | 74 | 0.130 |
Why?
| Infant Food | 2 | 1996 | 68 | 0.130 |
Why?
| Sensitivity and Specificity | 6 | 2016 | 1926 | 0.130 |
Why?
| Patient Education as Topic | 4 | 2011 | 731 | 0.130 |
Why?
| Menopause | 3 | 2011 | 249 | 0.130 |
Why?
| Surveys and Questionnaires | 12 | 2012 | 4549 | 0.130 |
Why?
| Inflammation | 2 | 2018 | 2427 | 0.130 |
Why?
| Polymerase Chain Reaction | 8 | 2008 | 1099 | 0.130 |
Why?
| HLA Antigens | 3 | 2008 | 240 | 0.130 |
Why?
| Polymorphism, Restriction Fragment Length | 7 | 2000 | 80 | 0.130 |
Why?
| Tumor Virus Infections | 4 | 2002 | 69 | 0.130 |
Why?
| Adolescent Development | 1 | 2013 | 97 | 0.130 |
Why?
| Postural Balance | 1 | 1995 | 197 | 0.120 |
Why?
| Models, Statistical | 5 | 2013 | 688 | 0.120 |
Why?
| Nitrates | 1 | 1992 | 81 | 0.120 |
Why?
| Managed Care Programs | 1 | 2013 | 156 | 0.120 |
Why?
| Water Supply | 1 | 1992 | 78 | 0.120 |
Why?
| Cultural Characteristics | 2 | 2002 | 72 | 0.120 |
Why?
| Health Services | 1 | 2013 | 100 | 0.120 |
Why?
| Depression | 1 | 2000 | 1117 | 0.120 |
Why?
| Hypercholesterolemia | 1 | 1992 | 101 | 0.120 |
Why?
| Treatment Outcome | 9 | 2020 | 8944 | 0.120 |
Why?
| Child of Impaired Parents | 1 | 2012 | 49 | 0.120 |
Why?
| Myocardial Infarction | 3 | 2006 | 1111 | 0.110 |
Why?
| Proinsulin | 1 | 2011 | 51 | 0.110 |
Why?
| Demography | 6 | 2020 | 294 | 0.110 |
Why?
| Poverty | 2 | 2006 | 443 | 0.110 |
Why?
| Reproducibility of Results | 6 | 2013 | 2877 | 0.110 |
Why?
| Physicians | 1 | 1998 | 681 | 0.110 |
Why?
| Pregnancy in Diabetics | 1 | 2012 | 88 | 0.110 |
Why?
| Sweetening Agents | 1 | 2011 | 53 | 0.110 |
Why?
| Self Concept | 1 | 2012 | 226 | 0.110 |
Why?
| Dietary Sucrose | 1 | 2011 | 55 | 0.110 |
Why?
| Down-Regulation | 1 | 2013 | 681 | 0.110 |
Why?
| Molecular Sequence Data | 7 | 2000 | 3120 | 0.110 |
Why?
| Topography, Medical | 1 | 2010 | 12 | 0.110 |
Why?
| Papillomavirus Infections | 4 | 2002 | 219 | 0.110 |
Why?
| Child Welfare | 1 | 2012 | 219 | 0.100 |
Why?
| Glucose-6-Phosphatase | 1 | 2009 | 32 | 0.100 |
Why?
| Family | 2 | 1993 | 569 | 0.100 |
Why?
| Small-Area Analysis | 2 | 2010 | 12 | 0.100 |
Why?
| Outpatients | 1 | 1992 | 232 | 0.100 |
Why?
| Hypolipidemic Agents | 1 | 2010 | 94 | 0.100 |
Why?
| Neoplasm Proteins | 2 | 2004 | 445 | 0.100 |
Why?
| Television | 1 | 2010 | 71 | 0.100 |
Why?
| Urban Health | 1 | 1989 | 87 | 0.100 |
Why?
| Lipid Metabolism | 3 | 2020 | 533 | 0.100 |
Why?
| Isosorbide Dinitrate | 1 | 2009 | 4 | 0.100 |
Why?
| Needs Assessment | 3 | 2016 | 343 | 0.100 |
Why?
| Hydralazine | 1 | 2009 | 8 | 0.100 |
Why?
| Cystic Fibrosis | 1 | 1998 | 872 | 0.100 |
Why?
| Promoter Regions, Genetic | 3 | 2003 | 1260 | 0.100 |
Why?
| Phenotype | 7 | 2014 | 3010 | 0.100 |
Why?
| Eating | 2 | 2004 | 361 | 0.100 |
Why?
| Bacteriuria | 1 | 1988 | 7 | 0.100 |
Why?
| Intermittent Claudication | 1 | 1990 | 106 | 0.100 |
Why?
| Residence Characteristics | 2 | 2010 | 280 | 0.100 |
Why?
| Maternal Age | 2 | 2006 | 121 | 0.100 |
Why?
| Adolescent Behavior | 1 | 2014 | 514 | 0.090 |
Why?
| Skinfold Thickness | 3 | 2012 | 54 | 0.090 |
Why?
| Biometry | 1 | 1988 | 68 | 0.090 |
Why?
| Fetal Growth Retardation | 1 | 2013 | 431 | 0.090 |
Why?
| Executive Function | 1 | 2013 | 370 | 0.090 |
Why?
| Nasal Mucosa | 1 | 1989 | 93 | 0.090 |
Why?
| HLA-DQ Antigens | 4 | 2008 | 189 | 0.090 |
Why?
| Ambulatory Care | 1 | 1992 | 456 | 0.090 |
Why?
| Ankle | 1 | 2008 | 62 | 0.090 |
Why?
| Marital Status | 2 | 2017 | 54 | 0.090 |
Why?
| HLA-DR Antigens | 4 | 2008 | 236 | 0.090 |
Why?
| Apolipoproteins | 2 | 1998 | 40 | 0.090 |
Why?
| Carcinoma in Situ | 4 | 1991 | 49 | 0.090 |
Why?
| Glucose Clamp Technique | 3 | 2010 | 206 | 0.090 |
Why?
| HLA-DQ beta-Chains | 3 | 2008 | 73 | 0.090 |
Why?
| Receptors, Drug | 1 | 2007 | 17 | 0.090 |
Why?
| Coronary Artery Disease | 2 | 2011 | 693 | 0.090 |
Why?
| Comorbidity | 4 | 2017 | 1597 | 0.090 |
Why?
| Smoking Prevention | 1 | 2008 | 164 | 0.090 |
Why?
| Vascular Diseases | 1 | 2010 | 227 | 0.080 |
Why?
| Adipose Tissue | 2 | 1991 | 662 | 0.080 |
Why?
| Minority Groups | 1 | 2008 | 199 | 0.080 |
Why?
| Probability | 3 | 2006 | 339 | 0.080 |
Why?
| Potassium Channels, Inwardly Rectifying | 1 | 2007 | 33 | 0.080 |
Why?
| Sequence Analysis, DNA | 3 | 2015 | 797 | 0.080 |
Why?
| Base Sequence | 7 | 1997 | 2323 | 0.080 |
Why?
| Vasodilator Agents | 1 | 2009 | 323 | 0.080 |
Why?
| Shoulder Injuries | 1 | 2006 | 51 | 0.080 |
Why?
| California | 2 | 1998 | 368 | 0.080 |
Why?
| South Carolina | 3 | 2012 | 37 | 0.080 |
Why?
| Potassium Channels | 1 | 2007 | 133 | 0.080 |
Why?
| ATP-Binding Cassette Transporters | 1 | 2007 | 129 | 0.080 |
Why?
| Carcinoma, Squamous Cell | 4 | 2001 | 554 | 0.080 |
Why?
| Papillomaviridae | 4 | 2002 | 122 | 0.080 |
Why?
| Trypsin Inhibitor, Kazal Pancreatic | 1 | 2005 | 4 | 0.080 |
Why?
| Amino Acid Substitution | 1 | 2007 | 309 | 0.080 |
Why?
| Infant, Very Low Birth Weight | 1 | 2006 | 66 | 0.080 |
Why?
| Nutritional Sciences | 1 | 2006 | 46 | 0.080 |
Why?
| Behavior Therapy | 1 | 2008 | 241 | 0.080 |
Why?
| Abbreviated Injury Scale | 1 | 2005 | 22 | 0.080 |
Why?
| Bias | 2 | 1999 | 182 | 0.070 |
Why?
| beta 2-Glycoprotein I | 3 | 1999 | 6 | 0.070 |
Why?
| Internet | 1 | 2010 | 627 | 0.070 |
Why?
| Staphylococcus aureus | 1 | 1989 | 384 | 0.070 |
Why?
| Lysine | 1 | 2007 | 229 | 0.070 |
Why?
| Joint Instability | 1 | 2006 | 138 | 0.070 |
Why?
| Statistics, Nonparametric | 3 | 2016 | 463 | 0.070 |
Why?
| Exercise Therapy | 3 | 2017 | 362 | 0.070 |
Why?
| Orthopedics | 1 | 2006 | 145 | 0.070 |
Why?
| Smoking Cessation | 1 | 2008 | 376 | 0.070 |
Why?
| Molecular Sequence Annotation | 2 | 2014 | 88 | 0.070 |
Why?
| Energy Metabolism | 2 | 2006 | 901 | 0.070 |
Why?
| Blood Group Antigens | 2 | 1997 | 18 | 0.070 |
Why?
| Computer Simulation | 2 | 2006 | 943 | 0.070 |
Why?
| Health Maintenance Organizations | 1 | 2004 | 106 | 0.070 |
Why?
| Cost of Illness | 1 | 2006 | 281 | 0.070 |
Why?
| Birth Order | 2 | 1994 | 12 | 0.070 |
Why?
| Vegetables | 2 | 2018 | 119 | 0.070 |
Why?
| Fruit | 2 | 2018 | 129 | 0.070 |
Why?
| Hypoglycemia | 2 | 2002 | 382 | 0.070 |
Why?
| Animal Technicians | 1 | 2003 | 5 | 0.070 |
Why?
| New York | 1 | 2003 | 118 | 0.070 |
Why?
| Medical Laboratory Personnel | 1 | 2003 | 13 | 0.070 |
Why?
| Animals, Laboratory | 1 | 2003 | 17 | 0.060 |
Why?
| Educational Measurement | 1 | 2006 | 300 | 0.060 |
Why?
| Multifactorial Inheritance | 1 | 2004 | 111 | 0.060 |
Why?
| Air Pollutants, Occupational | 1 | 2003 | 39 | 0.060 |
Why?
| Busulfan | 1 | 1982 | 21 | 0.060 |
Why?
| Hydroxyurea | 1 | 1982 | 31 | 0.060 |
Why?
| Remission Induction | 2 | 2014 | 262 | 0.060 |
Why?
| Alcohol Drinking | 3 | 1997 | 716 | 0.060 |
Why?
| Selenium | 1 | 2002 | 35 | 0.060 |
Why?
| Chlamydia Infections | 2 | 2000 | 57 | 0.060 |
Why?
| Leukemia, Myeloid | 1 | 1982 | 63 | 0.060 |
Why?
| Social Class | 2 | 2002 | 220 | 0.060 |
Why?
| Christianity | 1 | 1981 | 5 | 0.060 |
Why?
| Diet, Reducing | 2 | 2017 | 96 | 0.060 |
Why?
| Europe | 2 | 2013 | 348 | 0.060 |
Why?
| Receptors, Cytoplasmic and Nuclear | 1 | 2004 | 209 | 0.060 |
Why?
| Rehabilitation Centers | 1 | 2002 | 34 | 0.060 |
Why?
| Psychological Tests | 1 | 2002 | 148 | 0.060 |
Why?
| Recombinant Proteins | 1 | 2006 | 1459 | 0.060 |
Why?
| Endotoxins | 1 | 2003 | 261 | 0.060 |
Why?
| Tumor Suppressor Proteins | 1 | 2004 | 297 | 0.060 |
Why?
| Injury Severity Score | 2 | 2006 | 525 | 0.060 |
Why?
| Quantitative Trait, Heritable | 2 | 2004 | 141 | 0.060 |
Why?
| Dietary Proteins | 3 | 1997 | 124 | 0.060 |
Why?
| Anthropometry | 2 | 2010 | 197 | 0.060 |
Why?
| Hospitalization | 4 | 2009 | 1645 | 0.060 |
Why?
| Primary Prevention | 1 | 2003 | 214 | 0.060 |
Why?
| Measles | 1 | 2000 | 27 | 0.050 |
Why?
| Epidemiological Monitoring | 1 | 2021 | 48 | 0.050 |
Why?
| Whooping Cough | 1 | 2000 | 41 | 0.050 |
Why?
| Observational Studies as Topic | 1 | 2021 | 67 | 0.050 |
Why?
| Nursing Homes | 1 | 2002 | 128 | 0.050 |
Why?
| Homocysteine | 1 | 2001 | 137 | 0.050 |
Why?
| Cause of Death | 1 | 2002 | 382 | 0.050 |
Why?
| Disability Evaluation | 1 | 2002 | 305 | 0.050 |
Why?
| Texas | 2 | 2001 | 184 | 0.050 |
Why?
| Multigene Family | 2 | 2019 | 220 | 0.050 |
Why?
| Genetic Linkage | 3 | 2005 | 364 | 0.050 |
Why?
| Chromosome Mapping | 3 | 2004 | 570 | 0.050 |
Why?
| Immunization | 1 | 2003 | 396 | 0.050 |
Why?
| Microsatellite Repeats | 1 | 2000 | 170 | 0.050 |
Why?
| Psychometrics | 2 | 2006 | 658 | 0.050 |
Why?
| Introns | 1 | 2020 | 242 | 0.050 |
Why?
| Length of Stay | 1 | 2005 | 1057 | 0.050 |
Why?
| Diabetic Nephropathies | 2 | 1994 | 273 | 0.050 |
Why?
| Antibodies, Anticardiolipin | 1 | 1999 | 7 | 0.050 |
Why?
| Time-to-Pregnancy | 1 | 2019 | 4 | 0.050 |
Why?
| Atherosclerosis | 2 | 2015 | 301 | 0.050 |
Why?
| Semen Analysis | 1 | 2019 | 13 | 0.050 |
Why?
| Curriculum | 1 | 2006 | 809 | 0.050 |
Why?
| Genome-Wide Association Study | 2 | 2017 | 1108 | 0.050 |
Why?
| Antibodies, Antiphospholipid | 1 | 1999 | 25 | 0.050 |
Why?
| Combined Modality Therapy | 2 | 2014 | 1240 | 0.050 |
Why?
| Autoimmunity | 2 | 2014 | 771 | 0.050 |
Why?
| Leisure Activities | 2 | 2006 | 35 | 0.050 |
Why?
| Pregnancy Outcome | 2 | 2019 | 340 | 0.050 |
Why?
| Genetic Markers | 3 | 2004 | 402 | 0.050 |
Why?
| Taiwan | 1 | 1998 | 17 | 0.050 |
Why?
| Pennsylvania | 3 | 2001 | 119 | 0.050 |
Why?
| Sick Role | 1 | 1998 | 23 | 0.050 |
Why?
| Semen | 1 | 2019 | 37 | 0.050 |
Why?
| Phosphatidylserines | 1 | 1999 | 94 | 0.050 |
Why?
| Platelet Count | 1 | 1998 | 92 | 0.050 |
Why?
| Heart Failure | 2 | 2009 | 1874 | 0.050 |
Why?
| APACHE | 1 | 1998 | 64 | 0.050 |
Why?
| Physicians, Family | 1 | 2000 | 231 | 0.050 |
Why?
| Housing | 1 | 1999 | 108 | 0.050 |
Why?
| Social Adjustment | 1 | 1998 | 77 | 0.050 |
Why?
| Pilot Projects | 3 | 2017 | 1406 | 0.050 |
Why?
| RNA, Long Noncoding | 1 | 2020 | 156 | 0.050 |
Why?
| Propensity Score | 1 | 2019 | 224 | 0.050 |
Why?
| Disease Outbreaks | 1 | 2000 | 281 | 0.040 |
Why?
| Personality Inventory | 1 | 1998 | 157 | 0.040 |
Why?
| Healthy Lifestyle | 1 | 2018 | 31 | 0.040 |
Why?
| China | 1 | 1998 | 244 | 0.040 |
Why?
| Immunoglobulin M | 1 | 1999 | 234 | 0.040 |
Why?
| Family Characteristics | 1 | 2019 | 158 | 0.040 |
Why?
| Benzhydryl Compounds | 1 | 2018 | 61 | 0.040 |
Why?
| Alkanesulfonic Acids | 1 | 2017 | 17 | 0.040 |
Why?
| Caprylates | 1 | 2017 | 18 | 0.040 |
Why?
| Dietary Fats, Unsaturated | 1 | 1997 | 23 | 0.040 |
Why?
| alpha 1-Antichymotrypsin | 1 | 1997 | 4 | 0.040 |
Why?
| Behavior | 1 | 1998 | 117 | 0.040 |
Why?
| Pregnancy Rate | 1 | 2017 | 51 | 0.040 |
Why?
| Asian Americans | 1 | 2017 | 61 | 0.040 |
Why?
| Protein Conformation | 1 | 2020 | 972 | 0.040 |
Why?
| DNA Probes | 1 | 1996 | 68 | 0.040 |
Why?
| Task Performance and Analysis | 1 | 1998 | 181 | 0.040 |
Why?
| Binding Sites | 1 | 2020 | 1320 | 0.040 |
Why?
| Fluid Therapy | 1 | 1998 | 157 | 0.040 |
Why?
| Protective Factors | 1 | 2017 | 92 | 0.040 |
Why?
| Double-Blind Method | 3 | 2009 | 1670 | 0.040 |
Why?
| Nutritional Status | 1 | 1999 | 280 | 0.040 |
Why?
| Receptors, Immunologic | 1 | 1998 | 212 | 0.040 |
Why?
| Decision Trees | 1 | 1996 | 83 | 0.040 |
Why?
| Geriatric Assessment | 1 | 1998 | 175 | 0.040 |
Why?
| Milk Proteins | 1 | 1996 | 45 | 0.040 |
Why?
| Deoxyribonucleases, Type II Site-Specific | 2 | 1993 | 21 | 0.040 |
Why?
| Acculturation | 1 | 1996 | 55 | 0.040 |
Why?
| DNA Methylation | 1 | 2020 | 436 | 0.040 |
Why?
| Dental Caries | 1 | 1998 | 172 | 0.040 |
Why?
| Clinical Coding | 1 | 2016 | 22 | 0.040 |
Why?
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 3 | 2006 | 49 | 0.040 |
Why?
| Forced Expiratory Flow Rates | 1 | 1975 | 17 | 0.040 |
Why?
| Point Mutation | 1 | 1997 | 258 | 0.040 |
Why?
| Peak Expiratory Flow Rate | 1 | 1975 | 39 | 0.040 |
Why?
| Metabolome | 1 | 2019 | 295 | 0.040 |
Why?
| Blood Transfusion | 1 | 1998 | 288 | 0.040 |
Why?
| Environment | 2 | 2002 | 399 | 0.040 |
Why?
| Uterine Cervical Diseases | 1 | 1995 | 5 | 0.040 |
Why?
| Transcription, Genetic | 1 | 2003 | 1473 | 0.040 |
Why?
| Bronchitis | 1 | 1975 | 48 | 0.040 |
Why?
| Macular Degeneration | 1 | 1997 | 106 | 0.040 |
Why?
| Placebos | 2 | 2007 | 216 | 0.040 |
Why?
| DNA, Mitochondrial | 1 | 1997 | 200 | 0.040 |
Why?
| Genetic Loci | 1 | 2017 | 278 | 0.040 |
Why?
| Protein Tyrosine Phosphatases | 3 | 2006 | 143 | 0.040 |
Why?
| Transcription Factors | 1 | 2004 | 1636 | 0.040 |
Why?
| Fallopian Tube Diseases | 1 | 1994 | 6 | 0.040 |
Why?
| Hysterosalpingography | 1 | 1994 | 6 | 0.040 |
Why?
| Interviews as Topic | 2 | 2001 | 628 | 0.040 |
Why?
| Cleft Lip | 1 | 1994 | 37 | 0.040 |
Why?
| Chlamydia trachomatis | 1 | 1994 | 31 | 0.040 |
Why?
| Forecasting | 1 | 1997 | 399 | 0.040 |
Why?
| Blood Proteins | 1 | 1997 | 264 | 0.040 |
Why?
| Protein Binding | 1 | 2020 | 2112 | 0.040 |
Why?
| Adenocarcinoma | 1 | 2001 | 800 | 0.040 |
Why?
| Premenopause | 1 | 1995 | 117 | 0.040 |
Why?
| Genetic Testing | 3 | 2005 | 381 | 0.040 |
Why?
| Codon | 3 | 2003 | 95 | 0.040 |
Why?
| Cleft Palate | 1 | 1994 | 49 | 0.040 |
Why?
| Immunoglobulin G | 1 | 1999 | 787 | 0.030 |
Why?
| HLA-DQ alpha-Chains | 1 | 1994 | 18 | 0.030 |
Why?
| Overnutrition | 1 | 2014 | 41 | 0.030 |
Why?
| Infertility, Female | 1 | 1994 | 89 | 0.030 |
Why?
| Societies, Medical | 1 | 1998 | 764 | 0.030 |
Why?
| Antibodies, Bacterial | 1 | 1994 | 136 | 0.030 |
Why?
| Nutrition Policy | 1 | 2014 | 57 | 0.030 |
Why?
| Blood Glucose Self-Monitoring | 1 | 1998 | 441 | 0.030 |
Why?
| Multicenter Studies as Topic | 1 | 2014 | 219 | 0.030 |
Why?
| Fatty Acid-Binding Proteins | 2 | 2004 | 60 | 0.030 |
Why?
| Population Groups | 1 | 2013 | 57 | 0.030 |
Why?
| Kidney | 1 | 2021 | 1187 | 0.030 |
Why?
| Mental Health | 1 | 2018 | 411 | 0.030 |
Why?
| Adaptation, Psychological | 1 | 1998 | 572 | 0.030 |
Why?
| Lipoproteins, HDL3 | 1 | 1992 | 1 | 0.030 |
Why?
| Population Growth | 1 | 2012 | 12 | 0.030 |
Why?
| Lipoproteins, HDL2 | 1 | 1992 | 3 | 0.030 |
Why?
| Neoplasm Invasiveness | 3 | 2001 | 453 | 0.030 |
Why?
| CD8-Positive T-Lymphocytes | 1 | 1998 | 660 | 0.030 |
Why?
| Vaccination | 1 | 2000 | 932 | 0.030 |
Why?
| Chromosomes, Human | 1 | 1992 | 51 | 0.030 |
Why?
| Statistics as Topic | 3 | 2003 | 365 | 0.030 |
Why?
| Postmenopause | 1 | 1995 | 332 | 0.030 |
Why?
| Multiple Sclerosis | 2 | 1988 | 322 | 0.030 |
Why?
| Genetics, Population | 2 | 2004 | 230 | 0.030 |
Why?
| Autoimmune Diseases | 1 | 1996 | 432 | 0.030 |
Why?
| Diuretics | 1 | 1992 | 84 | 0.030 |
Why?
| Paper | 1 | 1992 | 10 | 0.030 |
Why?
| American Heart Association | 1 | 2014 | 278 | 0.030 |
Why?
| Health Education | 1 | 1995 | 321 | 0.030 |
Why?
| Blood Specimen Collection | 1 | 1992 | 37 | 0.030 |
Why?
| Glucose | 1 | 2017 | 866 | 0.030 |
Why?
| ROC Curve | 1 | 2013 | 486 | 0.030 |
Why?
| Intrauterine Devices | 1 | 1991 | 24 | 0.030 |
Why?
| Severity of Illness Index | 2 | 2008 | 2817 | 0.030 |
Why?
| Drug Administration Schedule | 2 | 2005 | 825 | 0.030 |
Why?
| Subcutaneous Fat | 1 | 2012 | 84 | 0.030 |
Why?
| Morbidity | 1 | 1992 | 255 | 0.030 |
Why?
| Thinness | 1 | 2012 | 90 | 0.030 |
Why?
| Estrogen Replacement Therapy | 1 | 1992 | 131 | 0.030 |
Why?
| Disease Susceptibility | 1 | 1994 | 356 | 0.030 |
Why?
| Child Nutritional Physiological Phenomena | 1 | 2012 | 100 | 0.030 |
Why?
| Databases, Factual | 1 | 2017 | 1184 | 0.030 |
Why?
| Income | 1 | 1992 | 163 | 0.030 |
Why?
| Acute Disease | 2 | 2006 | 997 | 0.030 |
Why?
| Genes | 1 | 1992 | 249 | 0.030 |
Why?
| Practice Patterns, Physicians' | 1 | 2000 | 1206 | 0.030 |
Why?
| Calcium, Dietary | 1 | 2011 | 51 | 0.030 |
Why?
| Metabolic Equivalent | 1 | 2010 | 3 | 0.030 |
Why?
| Syndrome | 2 | 2006 | 342 | 0.030 |
Why?
| Schools | 2 | 2006 | 354 | 0.030 |
Why?
| Cyclosporins | 1 | 1990 | 72 | 0.030 |
Why?
| Cattle | 1 | 1993 | 976 | 0.030 |
Why?
| Video Games | 1 | 2010 | 30 | 0.030 |
Why?
| Pulsatile Flow | 1 | 2010 | 61 | 0.030 |
Why?
| Adrenergic beta-Antagonists | 1 | 1992 | 366 | 0.030 |
Why?
| Pediatrics | 1 | 1998 | 1051 | 0.030 |
Why?
| Exercise Test | 1 | 2012 | 592 | 0.030 |
Why?
| Vitamin D-Binding Protein | 1 | 1989 | 16 | 0.020 |
Why?
| Fibrinogen | 1 | 2010 | 158 | 0.020 |
Why?
| Arm | 1 | 2010 | 97 | 0.020 |
Why?
| Reagent Strips | 1 | 1988 | 5 | 0.020 |
Why?
| Women's Health | 1 | 2011 | 251 | 0.020 |
Why?
| Extremities | 1 | 1990 | 116 | 0.020 |
Why?
| Elasticity | 1 | 2010 | 205 | 0.020 |
Why?
| Bicarbonates | 2 | 1985 | 46 | 0.020 |
Why?
| Randomized Controlled Trials as Topic | 1 | 2014 | 1130 | 0.020 |
Why?
| Arizona | 3 | 1978 | 65 | 0.020 |
Why?
| Puberty | 1 | 2010 | 139 | 0.020 |
Why?
| Body Height | 1 | 2009 | 187 | 0.020 |
Why?
| Genetic Carrier Screening | 1 | 2008 | 30 | 0.020 |
Why?
| Bayes Theorem | 1 | 2010 | 249 | 0.020 |
Why?
| Hospitals, Pediatric | 1 | 1992 | 489 | 0.020 |
Why?
| Diet, Fat-Restricted | 1 | 2008 | 86 | 0.020 |
Why?
| Leg | 1 | 2010 | 237 | 0.020 |
Why?
| Blood Flow Velocity | 1 | 2010 | 378 | 0.020 |
Why?
| Drug Combinations | 1 | 2009 | 295 | 0.020 |
Why?
| Sex | 1 | 1987 | 5 | 0.020 |
Why?
| Deoxyribonuclease HindIII | 2 | 2000 | 5 | 0.020 |
Why?
| Self Report | 1 | 2012 | 677 | 0.020 |
Why?
| HLA-DRB1 Chains | 1 | 2008 | 104 | 0.020 |
Why?
| C-Reactive Protein | 1 | 2010 | 362 | 0.020 |
Why?
| Biological Evolution | 1 | 1992 | 435 | 0.020 |
Why?
| Sulfonylurea Receptors | 1 | 2007 | 9 | 0.020 |
Why?
| Behavior, Addictive | 1 | 2008 | 95 | 0.020 |
Why?
| Caloric Restriction | 1 | 2008 | 120 | 0.020 |
Why?
| Drug Prescriptions | 1 | 2009 | 260 | 0.020 |
Why?
| Rotator Cuff | 1 | 2006 | 43 | 0.020 |
Why?
| Creatinine | 1 | 1988 | 448 | 0.020 |
Why?
| Body Size | 1 | 2007 | 97 | 0.020 |
Why?
| Hemodynamics | 1 | 2012 | 1097 | 0.020 |
Why?
| Rotator Cuff Injuries | 1 | 2006 | 55 | 0.020 |
Why?
| Angina, Unstable | 1 | 2006 | 92 | 0.020 |
Why?
| Epidemiology | 1 | 1986 | 19 | 0.020 |
Why?
| Mice | 1 | 2003 | 15510 | 0.020 |
Why?
| Histocompatibility Antigens Class II | 1 | 2008 | 382 | 0.020 |
Why?
| Interleukin-6 | 1 | 2010 | 705 | 0.020 |
Why?
| Insulin Antibodies | 2 | 1996 | 106 | 0.020 |
Why?
| Psychiatric Status Rating Scales | 1 | 2008 | 565 | 0.020 |
Why?
| Global Health | 1 | 2008 | 338 | 0.020 |
Why?
| Ketones | 1 | 1985 | 51 | 0.020 |
Why?
| Staphylococcal Infections | 1 | 1989 | 315 | 0.020 |
Why?
| Physical Endurance | 1 | 2006 | 263 | 0.020 |
Why?
| Shoulder Joint | 1 | 2006 | 145 | 0.020 |
Why?
| Nutrition Surveys | 1 | 2006 | 207 | 0.020 |
Why?
| Patient Selection | 1 | 2009 | 692 | 0.020 |
Why?
| Quality-Adjusted Life Years | 1 | 2005 | 113 | 0.020 |
Why?
| Markov Chains | 1 | 2005 | 127 | 0.020 |
Why?
| Mutation, Missense | 1 | 2007 | 324 | 0.020 |
Why?
| DNA Primers | 2 | 1996 | 597 | 0.020 |
Why?
| Uncoupling Protein 3 | 1 | 2004 | 11 | 0.020 |
Why?
| Abdomen | 1 | 2005 | 123 | 0.020 |
Why?
| Isoenzymes | 1 | 2006 | 367 | 0.020 |
Why?
| Fatty Acid-Binding Protein 7 | 1 | 2004 | 6 | 0.020 |
Why?
| Acidosis | 1 | 1985 | 93 | 0.020 |
Why?
| Pancreatitis | 1 | 2005 | 107 | 0.020 |
Why?
| Range of Motion, Articular | 1 | 2006 | 364 | 0.020 |
Why?
| Homeostasis | 2 | 2004 | 595 | 0.020 |
Why?
| Coronary Angiography | 1 | 2006 | 331 | 0.020 |
Why?
| Orthopedic Procedures | 1 | 2006 | 202 | 0.020 |
Why?
| DNA Mutational Analysis | 1 | 2005 | 420 | 0.020 |
Why?
| Attitude | 1 | 1986 | 228 | 0.020 |
Why?
| Case Management | 1 | 2004 | 71 | 0.020 |
Why?
| Congresses as Topic | 1 | 1985 | 209 | 0.020 |
Why?
| Skin Pigmentation | 1 | 2004 | 50 | 0.020 |
Why?
| Ion Channels | 1 | 2004 | 127 | 0.020 |
Why?
| Radioallergosorbent Test | 1 | 2003 | 7 | 0.020 |
Why?
| Dose-Response Relationship, Immunologic | 1 | 2003 | 97 | 0.020 |
Why?
| Teaching | 1 | 2006 | 242 | 0.020 |
Why?
| Hyperlipidemias | 1 | 2004 | 143 | 0.020 |
Why?
| Mexico | 2 | 1996 | 162 | 0.020 |
Why?
| Minisatellite Repeats | 1 | 2003 | 55 | 0.020 |
Why?
| Electrocardiography | 1 | 2006 | 656 | 0.020 |
Why?
| Vaginal Smears | 2 | 1995 | 44 | 0.020 |
Why?
| Asthma | 1 | 1975 | 1902 | 0.020 |
Why?
| Papanicolaou Test | 2 | 1995 | 43 | 0.020 |
Why?
| Referral and Consultation | 1 | 1988 | 626 | 0.020 |
Why?
| Skin Tests | 1 | 2003 | 135 | 0.020 |
Why?
| Self Efficacy | 1 | 2006 | 343 | 0.020 |
Why?
| Respiratory Hypersensitivity | 1 | 2003 | 82 | 0.020 |
Why?
| Autoantigens | 1 | 2006 | 411 | 0.020 |
Why?
| Memory | 1 | 2005 | 301 | 0.020 |
Why?
| Cost-Benefit Analysis | 1 | 2005 | 535 | 0.010 |
Why?
| Indiana | 1 | 1981 | 25 | 0.010 |
Why?
| Mitochondrial Proteins | 1 | 2004 | 227 | 0.010 |
Why?
| Vitamin B 6 | 1 | 2001 | 8 | 0.010 |
Why?
| Alabama | 1 | 2001 | 28 | 0.010 |
Why?
| Illinois | 1 | 2001 | 36 | 0.010 |
Why?
| New Mexico | 1 | 2001 | 66 | 0.010 |
Why?
| Florida | 1 | 2001 | 81 | 0.010 |
Why?
| Dissent and Disputes | 1 | 2000 | 13 | 0.010 |
Why?
| Bacteriological Techniques | 1 | 2001 | 63 | 0.010 |
Why?
| Philosophy, Medical | 1 | 2000 | 10 | 0.010 |
Why?
| Culture | 1 | 2002 | 135 | 0.010 |
Why?
| Mutation | 2 | 2004 | 3421 | 0.010 |
Why?
| Kringles | 1 | 2000 | 6 | 0.010 |
Why?
| Workplace | 1 | 2003 | 235 | 0.010 |
Why?
| Polymorphism, Single-Stranded Conformational | 1 | 2000 | 38 | 0.010 |
Why?
| Religion and Medicine | 1 | 2000 | 30 | 0.010 |
Why?
| Veterans | 1 | 2009 | 874 | 0.010 |
Why?
| Medicare | 1 | 2004 | 590 | 0.010 |
Why?
| Physician Assistants | 1 | 2000 | 61 | 0.010 |
Why?
| Neuropsychological Tests | 1 | 2005 | 1084 | 0.010 |
Why?
| Vitamins | 2 | 1991 | 141 | 0.010 |
Why?
| Nurse Practitioners | 1 | 2000 | 105 | 0.010 |
Why?
| Membrane Proteins | 1 | 2006 | 1091 | 0.010 |
Why?
| Transients and Migrants | 1 | 1979 | 26 | 0.010 |
Why?
| Animals | 3 | 2003 | 35194 | 0.010 |
Why?
| Cardiolipins | 1 | 1999 | 73 | 0.010 |
Why?
| Chromatography, High Pressure Liquid | 1 | 2001 | 596 | 0.010 |
Why?
| Panama | 1 | 1998 | 10 | 0.010 |
Why?
| DMF Index | 1 | 1998 | 22 | 0.010 |
Why?
| Chronic Disease | 1 | 2005 | 1666 | 0.010 |
Why?
| Tooth Extraction | 1 | 1998 | 25 | 0.010 |
Why?
| Low Density Lipoprotein Receptor-Related Protein-1 | 1 | 1998 | 17 | 0.010 |
Why?
| Enzyme-Linked Immunosorbent Assay | 1 | 2001 | 908 | 0.010 |
Why?
| Dental Restoration, Permanent | 1 | 1998 | 43 | 0.010 |
Why?
| Tooth Loss | 1 | 1998 | 31 | 0.010 |
Why?
| Lymphocyte Count | 1 | 1998 | 153 | 0.010 |
Why?
| Allergens | 1 | 2003 | 487 | 0.010 |
Why?
| Blood Preservation | 1 | 1982 | 292 | 0.010 |
Why?
| World Health Organization | 1 | 1998 | 111 | 0.010 |
Why?
| Metabolic Syndrome | 1 | 2002 | 384 | 0.010 |
Why?
| Isoelectric Focusing | 1 | 1997 | 40 | 0.010 |
Why?
| Proteinuria | 1 | 1998 | 103 | 0.010 |
Why?
| Antibodies, Viral | 1 | 2001 | 512 | 0.010 |
Why?
| CD4 Lymphocyte Count | 1 | 1998 | 300 | 0.010 |
Why?
| Nigeria | 1 | 1997 | 12 | 0.010 |
Why?
| Fundus Oculi | 1 | 1997 | 42 | 0.010 |
Why?
| Neoplasm Staging | 1 | 2001 | 1220 | 0.010 |
Why?
| Wisconsin | 1 | 1997 | 82 | 0.010 |
Why?
| Immunoblotting | 1 | 1997 | 375 | 0.010 |
Why?
| Photography | 1 | 1997 | 96 | 0.010 |
Why?
| Exons | 1 | 1997 | 316 | 0.010 |
Why?
| Africa | 1 | 1996 | 94 | 0.010 |
Why?
| Bacterial Infections | 1 | 1998 | 217 | 0.010 |
Why?
| Histocompatibility Testing | 1 | 1996 | 134 | 0.010 |
Why?
| Virus Diseases | 1 | 1998 | 181 | 0.010 |
Why?
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 1998 | 323 | 0.010 |
Why?
| Thrombosis | 1 | 1999 | 264 | 0.010 |
Why?
| England | 1 | 1975 | 58 | 0.010 |
Why?
| Quality Control | 1 | 1996 | 176 | 0.010 |
Why?
| Data Interpretation, Statistical | 1 | 1998 | 344 | 0.010 |
Why?
| Guideline Adherence | 1 | 2000 | 527 | 0.010 |
Why?
| Erythrocytes | 1 | 2001 | 602 | 0.010 |
Why?
| Trichomonas Infections | 1 | 1995 | 8 | 0.010 |
Why?
| Condylomata Acuminata | 1 | 1995 | 9 | 0.010 |
Why?
| Marriage | 1 | 1997 | 111 | 0.010 |
Why?
| Cholesterol, Dietary | 1 | 1975 | 26 | 0.010 |
Why?
| Pneumonia | 2 | 1983 | 557 | 0.010 |
Why?
| Receptors, Cell Surface | 1 | 1998 | 401 | 0.010 |
Why?
| Cervix Uteri | 1 | 1995 | 51 | 0.010 |
Why?
| Sex Ratio | 1 | 1994 | 15 | 0.010 |
Why?
| Gonorrhea | 1 | 1995 | 44 | 0.010 |
Why?
| Eczema | 1 | 1975 | 68 | 0.010 |
Why?
| T-Lymphocyte Subsets | 1 | 1998 | 451 | 0.010 |
Why?
| False Positive Reactions | 1 | 1994 | 138 | 0.010 |
Why?
| Models, Biological | 1 | 2002 | 1843 | 0.010 |
Why?
| Mental Disorders | 1 | 2002 | 929 | 0.010 |
Why?
| Tomography, X-Ray Computed | 1 | 2003 | 2370 | 0.010 |
Why?
| Medical Records | 1 | 1994 | 182 | 0.010 |
Why?
| Primary Health Care | 1 | 2004 | 1486 | 0.010 |
Why?
| DNA, Viral | 1 | 1995 | 442 | 0.010 |
Why?
| Survival Analysis | 1 | 1996 | 1414 | 0.010 |
Why?
| Intrauterine Devices, Copper | 1 | 1991 | 9 | 0.010 |
Why?
| Sexual Behavior | 1 | 1995 | 444 | 0.010 |
Why?
| Contraceptives, Oral | 1 | 1990 | 32 | 0.010 |
Why?
| Laparoscopy | 1 | 1994 | 383 | 0.010 |
Why?
| Altitude | 1 | 1994 | 457 | 0.010 |
Why?
| Random Allocation | 1 | 1990 | 402 | 0.010 |
Why?
| Sexual Partners | 1 | 1990 | 149 | 0.010 |
Why?
| Genital Diseases, Female | 1 | 1987 | 26 | 0.010 |
Why?
| Milk, Human | 1 | 1988 | 136 | 0.010 |
Why?
| Dose-Response Relationship, Drug | 1 | 1991 | 2226 | 0.010 |
Why?
| Hydrogen-Ion Concentration | 1 | 1985 | 596 | 0.000 |
Why?
| Inhalation | 1 | 1983 | 29 | 0.000 |
Why?
| Disseminated Intravascular Coagulation | 1 | 1983 | 33 | 0.000 |
Why?
| Intubation, Intratracheal | 1 | 1983 | 188 | 0.000 |
Why?
| Insulin Infusion Systems | 1 | 1985 | 323 | 0.000 |
Why?
| Clinical Trials as Topic | 1 | 1986 | 1002 | 0.000 |
Why?
| Hawaii | 1 | 1979 | 26 | 0.000 |
Why?
| Japan | 1 | 1979 | 94 | 0.000 |
Why?
| Minnesota | 1 | 1978 | 93 | 0.000 |
Why?
| Feeding Behavior | 1 | 1979 | 562 | 0.000 |
Why?
|
|
Hamman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|